InsidersTradesSigma
Explore the complete record of transactions filed by Duvall Diantha, Chief Financial Officer. Director active across 1 companies, notably Genocea Biosciences, INC.. Cumulatively, 4 disclosures have been published. Total volume traded: €3k. The latest transaction was filed on 2 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Diantha Duvall serves as Chief Financial Officer at Genocea Biosciences, Inc. She is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. With a strong background in the biopharmaceutical sector, Diantha Duvall is committed to ensuring the financial health of Genocea and supporting its strategic growth. Her role is essential in ensuring compliance with financial regulations.